- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/52 - CytokinesLymphokinesInterferons
Patent holdings for IPC class C07K 14/52
Total number of patents in this class: 1659
10-year publication summary
|
73
|
88
|
104
|
113
|
107
|
112
|
98
|
110
|
107
|
61
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19961 |
25 |
| Regeneron Pharmaceuticals, Inc. | 4288 |
22 |
| Yale University | 2394 |
21 |
| Genentech, Inc. | 3976 |
17 |
| The Trustees of the University of Pennsylvania | 4323 |
17 |
| The Board of Trustees of the Leland Stanford Junior University | 6428 |
16 |
| Vib VZW | 881 |
16 |
| The General Hospital Corporation | 4740 |
15 |
| Memorial Sloan-Kettering Cancer Center | 1931 |
13 |
| Universiteit Gent | 1335 |
13 |
| Institute for Research in Biomedicine (IRB) | 40 |
12 |
| Lipoxen Technologies Limited | 48 |
12 |
| Akamis Bio Limited | 57 |
12 |
| Arla Foods amba | 545 |
11 |
| Washington University | 1616 |
11 |
| Ith Immune Therapy Holdings | 16 |
11 |
| Osaka University | 3379 |
10 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3166 |
10 |
| Wake Forest University Health Sciences | 722 |
10 |
| Immunitybio, Inc. | 378 |
10 |
| Other owners | 1375 |